Literature DB >> 2480627

Overview of biological response modifiers.

E D Staren1, R Essner, J S Economou.   

Abstract

The immune system is regulated by a variety of lymphokines, monokines, and colony-stimulating factors. Most have now been cloned and it is clear that these cytokines have a broad range of overlapping immunological, inflammatory, and physiological properties. Some of these cytokines might favorably influence the biological therapy of cancer and they have been collectively referred to by clinicians as "biological response modifiers." This review summarizes current knowledge about the molecular biology and biological properties of most of the common cytokines and provides a brief survey of their therapeutic potential in patients with cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480627     DOI: 10.1002/ssu.2980050603

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  5 in total

Review 1.  Cytokines as biological response modifiers.

Authors:  R C Rees
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

Review 2.  Viral hepatitis screening guideline before biological drug use in rheumatic patients.

Authors:  Ömer Karadağ; Timuçin Kaşifoğlu; Birol Özer; Sabahattin Kaymakoğlu; Yeşim Kuş; Murat İnanç; Gökhan Keser; Sedat Kiraz
Journal:  Eur J Rheumatol       Date:  2015-10-28

Review 3.  Cytokine-mediated gene therapy for cancer.

Authors:  A R Miller; W H McBride; K Hunt; J S Economou
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

4.  Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors.

Authors:  Y L Matory; M Chen; P S Goedegebuure; T J Eberlein
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

5.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.